Shanghai Outdo Biotech Co., Ltd.

Shanghai Outdo Biotech Co., Ltd(Outdo Biotech )is a national high-technology enterprises in Shanghai, which is subordinate to Shanghai Biochip Co., Ltd. (National Engineering Center Biochip at Shanghai), in line with all patient-centered(C)development purposes, focusing on the standardized construction of biobank (B), discipline construction (D), translational research (T) and precision medicine (M). The national center was established in 2001 by the National Development and Reform Commission with an investment of RMB 290 million. It is a representative unit in the field of Omics, high-throughput technique and molecular precision medicine in China, which is the secretariat and chairman of the National Technical Committee 559 on Bio-specimen of Standardization Administration of China(TC559), Biobank Branch of China Medicinal Biotech Association (BBCMBA) and the Integration Research Branch for Cancer Biospecimen of China Anti-Cancer Association.

Since its establishment 16 years ago, Outdo Biotech preserve the optimism, forge ahead, independent innovation, eager to progress, it focusing on the key links of industrial development such as clinical translation research and application striving to build the industrial chain of national standardized biobannk, clinical molecular and translational medicine platform, and provide a complete channel for rapid clinical translation research and personalized precision medicine from "sample" to "product". Everything is patient-centered, Outdo Biotech is the first to advocate in China and promote innovative overall solutions for CBDTM model of key disciplines of clinical medicine.